好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Clinical and Preclinical Comparison of the Pharmacokinetic Parameters of AVI-4658, a Phosphorodiamidate Morpholino Oligomer for the Treatment of Duchenne Muscular Dystrophy
Muscle Disease/Neuromuscular Junction
(-)
066
Authors/Disclosures
Peter Sazani, PhD No disclosure on file
No disclosure on file
Stephen B. Shrewsbury, MD (Impel Pharmaceuticals) Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Gregory F. Wu, MD, FAAN Dr. Wu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Progentec. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wu has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimmunology. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Department of Justice. The institution of Dr. Wu has received research support from EMD Serono. The institution of Dr. Wu has received research support from Biogen.